Pal Aukrust

Pal Aukrust

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 547 publications

Cetoleic acid-rich fish oil increases plasma levels of EPA and DHA in healthy volunteers: a double-blinded, randomised, controlled trial.

Cetoleic acid-rich fish oil increases plasma levels of EPA and DHA in healthy volunteers: a double-blinded, randomised, controlled trial.

Journal: The British journal of nutrition
Published: July 30, 2026

Cetoleic acid rich fish oil increases plasma levels of eicosapentaenoic and docosapentaenoic acids in healthy volunteers: a double-blinded, randomised, controlled trial.

Cetoleic acid rich fish oil increases plasma levels of eicosapentaenoic and docosapentaenoic acids in healthy volunteers: a double-blinded, randomised, controlled trial.

Journal: The British journal of nutrition
Published: July 30, 2026

Dysregulated Proteins in Plasma Distinguishing Loeys-Dietz Syndrome from Other Heritable Thoracic Aortic Disease - An Explorative Study.

Dysregulated Proteins in Plasma Distinguishing Loeys-Dietz Syndrome from Other Heritable Thoracic Aortic Disease - An Explorative Study.

Journal: Scandinavian cardiovascular journal : SCJ
Published: July 07, 2026

Secreted frizzled-related protein 3 is associated with metabolic disturbances in gestational diabetes.

Secreted frizzled-related protein 3 is associated with metabolic disturbances in gestational diabetes.

Journal: Frontiers in endocrinology
Published: June 10, 2026

Altered duodenal N6-methyladenosine levels in common variable immunodeficiency associate with duodenal microbiota.

Altered duodenal N6-methyladenosine levels in common variable immunodeficiency associate with duodenal microbiota.

Journal: Frontiers in immunology
Published: May 08, 2026

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 23, 2026

C-X-C Motif Chemokine Ligand 5 (CXCL5) Exhibits a U-Shaped Risk Profile for Mortality in Patients with Suspected Coronary Chest Pain.

C-X-C Motif Chemokine Ligand 5 (CXCL5) Exhibits a U-Shaped Risk Profile for Mortality in Patients with Suspected Coronary Chest Pain.

Journal: International journal of molecular sciences
Published: February 13, 2026

Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial.

Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial.

Journal: The Lancet. Infectious diseases
Published: February 11, 2026

Gut microbiota derived indoles are altered and associate with immune activation in moderate and severe carotid stenosis.

Gut microbiota derived indoles are altered and associate with immune activation in moderate and severe carotid stenosis.

Journal: Frontiers in immunology
Published: January 26, 2026

Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques - a pilot study.

Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques - a pilot study.

Journal: Frontiers in immunology
Published: January 19, 2026

Plasma levels of adiponectin and risk of future incident venous thromboembolism.

Plasma levels of adiponectin and risk of future incident venous thromboembolism.

Journal: Journal of thrombosis and haemostasis : JTH
Published: January 15, 2026

Circulating MALAT1 in Preeclampsia and Association With Cardiometabolic Risk.

Circulating MALAT1 in Preeclampsia and Association With Cardiometabolic Risk.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 07, 2026
Showing 1-12 of 547

Last Updated: 09/26/2026